Development of an ideal drug engine to provide biologics with an inherent low immunogenicity risk

• Forschungsstelle: INNOSUISSE
• Projektnummer: 26689.1 PFLS-LS
• Projekttitel Englisch: Development of an ideal drug engine to provide biologics with an inherent low immunogenicity risk

Kurzbeschreibung (Deutsch)

Development of an ideal drug engine to provide biologics with an inherent low immunogenicity risk

Kurzbeschreibung (Englisch)

Abstract (Deutsch)

We envision an ideal drug engine based on a human protein providing novel biologics to address unmet medical needs by merging the low immunogenicity risk of human antibodies and the excellent versatility, efficient developability and intellectual property benefits of an alternative scaffold.

Abstract (Englisch)